Moderna to Host Conference Call on COVID-19 Variants Announcement on Monday, Jan. 25
January 25, 2021
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 25, 2021-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA
(mRNA) therapeutics and vaccines, today announced that it will hold a conference call today, Monday, January 25 at 4:30 pm ET on the Company’s
announcement that results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity
against emerging strains of SARS-CoV-2.